Sunday, December 22

USA: The renowed physician Dr Ramesh Babu Peramsetty, an Indian-origin doctor was shot in US in Tuscaloosa, a city in Alabama, on Friday. Dr. Ramesh succumbed to the shot on the spot. Dr Ramesh, who was from Andhra Pradesh’s Tirupati district, was one of the founders and medical director of a group of local medical officers operating as the Crimson Network. He was known for his contributions in the field of healthcare and also practiced as a physician in Tuscaloosa.

“As many are aware at this moment, we have been informed of Dr. Ramesh Peramsetty’s passing. The Peramsetty family ask for us to give them privacy as they grieve his passing. They have received abundant outpouring of love and faith. We will continue to honor him as he would want us to do. Thank you for your understanding,” the Crimson Care Network Team said in a Facebook post. The Crimson Care Network said its team “is prepared to make more statements within the next few days.”

He worked in Tuscaloosa and four other locations and was specialised in Emergency Medicine and Family Medicine, it says. He was also affiliated with Diploma in Child Health (DCH) Regional Medical Center. As per local reports, a street in Tuscaloosa was named after him due to his significant contributions in the medical profession. He also did extensive work during the Covid-19 pandemic and also received awards for the same, reports suggest. He is survived by his wife, two sons and two daughters and all are settled in the US, as per reports.

Share.
Leave A Reply

Doctor Post is a health news portal tailored to provide updates for medical and healthcare professionals, while remaining open to others interested in accessing general health information. The content on Doctor Post is carefully created and/or edited by a dedicated team of doctors, healthcare researchers, and scientific writers.

© 2024 Doctor Post. All Rights Reserved. Created and Maintained by Creative web Solution

Disclaimer: Use of the site is governed by our terms of use, privacy policy, and advertisement policy. For further details, please refer to our Disclaimer.

Exit mobile version